Scientists hunt for clues in the blood to unlock mysterious brain lymphoma

NCT ID NCT07188077

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study compares blood samples from 20 people with primary central nervous system lymphoma (a rare brain cancer) to samples from people with other types of lymphoma and healthy volunteers. Researchers will look at small molecules (metabolites) and immune cells to find differences that may help diagnose or understand the disease better. No new treatment is given; participants only provide samples and have regular check-ups.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIFFUSE LARGE B-CELL LYMPHOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

diffuse large B-cell lymphoma primary central nervous system lymphoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • The First Affiliated Hospital of Fujian Medical University

    RECRUITING

    Fuzhou, Fujian, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact